Sunho Biologics

Executive Summary

Sunho Biologics is a privately held Chinese biotechnology company established in 2016 and headquartered in Shanghai. The company specializes in the research, development, and manufacturing of high-quality monoclonal antibodies and recombinant proteins, serving as a critical supplier of reagents and tools for biomedical research, diagnostics, and therapeutic discovery. With a workforce of 200–500 employees, Sunho Biologics caters to academic institutions, diagnostic companies, and biopharmaceutical firms globally. Its focus on quality and broad application areas positions it as a key enabler in the life sciences value chain, though it operates in a competitive landscape with both domestic and international players. The company's platform stage and lack of disclosed pipeline or financial details limit visibility into its specific growth trajectory, but its established presence in the reagent and protein market suggests a steady revenue base from ongoing product sales and partnerships.